Sheep anti Human bcl-xl

Nordic MuBio
Product Code: EXA-A110P
Product Group: Primary Antibodies
Supplier: Nordic MuBio
CodeSizePrice
EXA-A110P100 ug£316.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Sheep
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Shipping:
room temperature
Storage:
Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles

Further Information

Applications Description:
Application: Western Blot at 1-5 ug/ml. Positive control MCF-7 cells.
Background:
bcl-x is a bcl-2-related gene that can function as a regulator of programmed cell death (apoptosis) independent of bcl-2. Alternative splicing results in two distinct bcl-x mRNAs. The larger mRNA gives rise to a protein product, bcl-xl, which is similar in size and predicted structure to bcl-2 (1). The smaller mRNA gives rise to bcl-xS. bcl-x immunoreactivity has been detected in a wide variety of cell types and the protein is typically present in the cytosol in association with the mitochondrial periphery, a property shared with bcl-2 however membrane bound forms of bcl-x have been demonstrated in thymocytes (2-4). Following the induction of apoptosis all of the bcl-x protein shifts to the membrane form (2). Of the two isoforms of bcl-x, the long (bcl-xl) is the most abundant mRNA species expressed in embryonic and adult tissues and most likely differs from bcl-2 in its regulatory activity on cell differentiation through controlled tissue specific expression (1,3). Like its homolog bcl-2, bcl-x undergoes phosphorylation, a modification that requires that a specific 60 amino acid loop region be intact, which in turn appears to regulate activity (5,6). Structurally, based on 3D-structure analysis, bcl-x forms pH sensitive cation-selective ion channels in membranes a property shared with the pore forming domains of several bacterial toxins (7). Bcl-xl has been shown to modify the cell?s response to oxidants, to participate in resistance to chemotherapeutic agents and radiation, and to play a key role in the development of the developing CNS (8-10).
Caution:
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.
Concentration:
See vial for concentration
Field of Interest:
Apoptosis
Formulation:
Provided as solution in phosphate buffered saline with 0.08% sodium azide
Functional Analysis:
Western Blotting
Immunogen:
A synthetic peptide corresponding to amino acids 3 to 14 of the human bcl-xl sequence
Product Form:
Unconjugated
Product Stability:
Products are stable for one year from purchase when stored properly
Purification Method:
Ammonium Sulfate Precipitation
Synonyms:
hbcl-xl, sheep anti human bcl-xl, bclxl, bcl xl, bclx, bcl2L1, BCL2L
UniProt:
Q07817 (Human)

References

1. Boise L.H., et al. (1993) Cell 74: 597-608.

2. Krajewski S., et al. (1994) Cancer Res 54:5501-5507.

3. Gonzalez-Garcia M., et al. (1994) Development 120: 3033-3042.

4. Hsu, Y.T., et al. (1997) Proc. Natl. Acad. Sci USA 94: 3668-3672.

5. Benito, A., et al. (1997) Leukemia 11 940-944.

6. Chang, B.S., et al. (1997) EMBO J. 16: 968-977.

7. Minn, A.J., et al. (1997) Nature 385: 353-357.

8. Fang W., et al. (1995) J Immunol 155: 66-75.

9. Datta R., et al. (1995) Cell Growth Differ 6:363-370.

10. Shindler, K.S., et al. (1997) J. Neurosci. 17:3112-3119.